Insights into the Drug Repositioning Applied to the Alzheimer's Disease Treatment and Future Perspectives

E-ISSN： 1875-5828|15|12|1161-1178

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.15, Iss.12, 2018-11, pp. : 1161-1178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cdk5 as a Drug Target for the Treatment of Alzheimer’s Disease

By Lau Lit-Fui Seymour Patricia A. Sanner Mark A. Schachter Joel B.

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 267-274

Humana Press, Inc

Access to resources Recommend Favorite

Amyloid precursor protein and tau transgenic models of Alzheimer’s disease: insights from the past and directions for the future

By Sahara Naruhiko Lewis Jada

Future Neurology, Vol. 5, Iss. 3, 2010-05 ,pp. : 411-420

Future Medicine

Access to resources Recommend Favorite

Controversies in Alzheimer's disease drug development

By Cummings Jeffrey

International Review of Psychiatry, Vol. 20, Iss. 4, 2008-08 ,pp. : 389-395

Informa Healthcare

Access to resources Recommend Favorite

The effect of neuronal activity and connectivity on Alzheimer's disease: a new direction and its implications for future treatment strategies

By de Haan Willem

Neurodegenerative Disease Management, Vol. 3, Iss. 2, 2013-04 ,pp. : 93-95

Future Medicine

Access to resources Recommend Favorite

Acetylcholinesterase: A multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer’s disease

By Greenblatt Harry Dvir Hay Silman Israel Sussman Joel

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 369-383

Humana Press, Inc

Access to resources Recommend Favorite